World's Best Scientists 2026 revealed!
Award Badge
Medicine
Spain
2023

D-Index & Metrics

Medicine

D-Index
139
Citations
153561
World Ranking
1713
National Ranking
19

Research.com Recognitions

  • 2023 - Research.com Medicine in Spain Leader Award

Overview

Jordi Bruix is affiliated with the University of Barcelona in Spain and primarily conducts research in the field of medicine, with a focus on hepatology. Their work includes significant contributions to the study and treatment of hepatocellular carcinoma (HCC) and other liver-related diseases.

The scientist has published extensively in several key scientific venues, including:

  • Journal of Hepatology (26 publications)
  • Journal of Clinical Oncology (8 publications)
  • Annals of Oncology (7 publications)
  • Cancer Treatment Reviews (6 publications)
  • Hepatology (5 publications)

Bruix's research covers subfields such as hepatology, oncology, epidemiology, pulmonary and respiratory medicine, and molecular biology. The main topics they explore include:

  • Hepatocellular carcinoma treatment and prognosis
  • Liver disease diagnosis and treatment
  • Pancreatic and hepatic oncology research
  • Cancer immunotherapy and biomarkers
  • Hepatitis C virus research
  • Liver disease and transplantation
  • Colorectal cancer treatments and studies

The following are some recent papers authored or co-authored by Bruix and colleagues, along with their publication years and venues:

  • Systemic treatment of hepatocellular carcinoma: An EASL position paper, 2021, Journal of Hepatology
  • BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update, 2021, Journal of Hepatology
  • Cholangiocarcinoma 2020: the next horizon in mechanisms and management, 2020, Nature Reviews Gastroenterology & Hepatology
  • Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study, 2021, Journal of Clinical Oncology
  • Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression, 2021, Clinical Gastroenterology and Hepatology

Frequent collaborators with Bruix include:

  • María Reig
  • Alejandro Forner
  • Víctor Sapena
  • Jordi Rimola
  • Marco Sanduzzi-Zamparelli

Best Publications

  • Sorafenib in Advanced Hepatocellular Carcinoma

    Josep M. Llovet;Sergio Ricci;Vincenzo Mazzaferro;Philip Hilgard

  • Management of hepatocellular carcinoma: An update

    Jordi Bruix;Morris Sherman

  • Management of hepatocellular carcinoma.

    Jordi Bruix;Morris Sherman

  • Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

    Jordi Bruix;Morris Sherman;Josep M Llovet;Michel Beaugrand

  • PROGNOSIS OF HEPATOCELLULAR CARCINOMA : THE BCLC STAGING CLASSIFICATION

    Josep M. Llovet;Concepció Brú;Jordi Bruix

  • Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.

    Josep M Llovet;Maria Isabel Real;Xavier Montaña;Ramon Planas

  • Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

    Josep M. Llovet;Jordi Bruix

  • Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

    Jordi Bruix;Shukui Qin;Philippe Merle;Alessandro Granito

  • BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system. The 2022 update.

    M. Reig;A. Forner;J. Rimola;J. Ferrer-Fábrega

  • Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

    Vincenzo Mazzaferro;Josep M Llovet;Rosalba Miceli;Sherrie Bhoori

  • Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation

    Josep M. Llovet;Josep Fuster;Jordi Bruix

  • Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

    Josep M. Llovet;Adrian M. Di Bisceglie;Jordi Bruix;Barnett S. Kramer

  • Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.

    Jordi Bruix;Maria Reig;Morris Sherman

  • Cholangiocarcinoma 2020: the next horizon in mechanisms and management

    Jesus M. Banales;Jesus M. Banales;Jesus M. Banales;Jose J. G. Marin;Jose J. G. Marin;Angela Lamarca;Angela Lamarca;Pedro M. Rodrigues

  • Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials

    Josep M. Llovet;Javier Bustamante;Antoni Castells;Ramon Vilana

  • Hepatocellular carcinoma: clinical frontiers and perspectives

    Jordi Bruix;Gregory J Gores;Vincenzo Mazzaferro

  • Current strategy for staging and treatment: the BCLC update and future prospects.

    Alejandro Forner;María E. Reig;Carlos Rodriguez de Lope;Jordi Bruix

  • Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

    Yujin Hoshida;Augusto Villanueva;Masahiro Kobayashi;Judit Peix

  • Prognostic prediction and treatment strategy in hepatocellular carcinoma

    Jordi Bruix;Josep M. Llovet

  • Molecular targeted therapies in hepatocellular carcinoma.

    Josep M. Llovet;Josep M. Llovet;Jordi Bruix

Frequent Co-Authors

Josep M. Llovet
Josep M. Llovet University of Barcelona
Carmen Ayuso
Carmen Ayuso Hospital Universitario Fundación Jiménez Díaz
Vincenzo Mazzaferro
Vincenzo Mazzaferro University of Milan
Juan Rodés
Juan Rodés University of Barcelona
Maria Varela
Maria Varela Complutense University of Madrid
Bruno Sangro
Bruno Sangro University of Navarra
Myron Schwartz
Myron Schwartz Icahn School of Medicine at Mount Sinai
Xavier Forns
Xavier Forns University of Barcelona
Masatoshi Kudo
Masatoshi Kudo Kindai University
Swan N. Thung
Swan N. Thung Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The path to a career in medicine extends beyond traditional MD programs. Many aspiring healthcare professionals explore diverse online degree options that provide flexibility, affordability, and alternative routes to clinical roles.

For those interested in advancing nursing careers, phd in nursing online programs offer a way to specialize in research or education while balancing professional responsibilities. If cost is a major factor, exploring the cheapest accredited online rn to bsn programs can make degree completion more accessible.

Non-nursing majors looking to enter the nursing field can consider online direct entry msn programs for non-nursing majors, which streamline the transition into advanced clinical roles. Additionally, high school graduates may benefit from direct admit nursing programs for a more direct pathway to licensure and practice.

Each option opens unique doors within the broader healthcare sector, allowing students to tailor their education and career development to their specific goals, backgrounds, and financial needs.

Best Scientists Citing Jordi Bruix

Trending Scientists